Tapentadol CG5503

tapentadol · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tapentadol CG5503, covering 2009-07-08 to 2009-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety [Phase 3]

See pricing